Clarius Group LLC’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Hold |
212,500
| – | – | 0.03% | 224 |
|
|
2025
Q1 | $357K | Buy |
212,500
+100,000
| +89% | +$168K | 0.02% | 305 |
|
|
2024
Q4 | $183K | Buy |
112,500
+49,316
| +78% | +$80.4K | 0.01% | 434 |
|
|
2024
Q3 | $263K | Hold |
63,184
| – | – | 0.02% | 349 |
|
|
2024
Q2 | $345K | Buy |
63,184
+16,359
| +35% | +$89.3K | 0.02% | 290 |
|
|
2024
Q1 | $468K | Hold |
46,825
| – | – | 0.03% | 236 |
|
|
2023
Q4 | $191K | Hold |
46,825
| – | – | 0.02% | 461 |
|
|
2023
Q3 | $181K | Hold |
46,825
| – | – | 0.02% | 442 |
|
|
2023
Q2 | $279K | Hold |
46,825
| – | – | 0.02% | 410 |
|
|
2023
Q1 | $153K | Hold |
46,825
| – | – | 0.01% | 489 |
|
|
2022
Q4 | $185K | Buy |
46,825
+34,325
| +275% | +$136K | 0.02% | 486 |
|
|
2022
Q3 | $75K | Hold |
12,500
| – | – | 0.01% | 478 |
|
|
2022
Q2 | $80K | Hold |
12,500
| – | – | 0.01% | 460 |
|
|
2022
Q1 | $194K | Hold |
12,500
| – | – | 0.02% | 476 |
|
|
2021
Q4 | $194K | Hold |
12,500
| – | – | 0.02% | 476 |
|
|
2021
Q3 | $282K | Hold |
12,500
| – | – | 0.03% | 330 |
|
|
2021
Q2 | $246K | Buy |
+12,500
| New | +$246K | 0.02% | 353 |
|